Hypochromic erythrocytes as prognostic indicator of survival among patients with systemic sclerosis screened for pulmonary hypertension
O. Gordjani (Heidelberg, Germany), P. Xanthouli (Heidelberg, Germany), C. Eichstadt (Heidelberg, Germany), N. Benjamin (Heidelberg, Germany), B. Egenlauf (Heidelberg, Germany), S. Harutyunova (Heidelberg, Germany), A. Marra (Napoli, Italy), V. Theobald (Heidelberg, Germany), N. Milde (Heidelberg, Germany), C. Nagel (Heidelberg, Germany), N. Blank (Heidelberg, Germany), H. Lorenz (Heidelberg, Germany), E. Grünig (Heidelberg, Germany)
Source: International Congress 2022 – Diagnosis and epidemiology in pulmonary hypertension
Session: Diagnosis and epidemiology in pulmonary hypertension
Session type: Thematic Poster
Number: 1976
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Gordjani (Heidelberg, Germany), P. Xanthouli (Heidelberg, Germany), C. Eichstadt (Heidelberg, Germany), N. Benjamin (Heidelberg, Germany), B. Egenlauf (Heidelberg, Germany), S. Harutyunova (Heidelberg, Germany), A. Marra (Napoli, Italy), V. Theobald (Heidelberg, Germany), N. Milde (Heidelberg, Germany), C. Nagel (Heidelberg, Germany), N. Blank (Heidelberg, Germany), H. Lorenz (Heidelberg, Germany), E. Grünig (Heidelberg, Germany). Hypochromic erythrocytes as prognostic indicator of survival among patients with systemic sclerosis screened for pulmonary hypertension. 1976
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|